VedaBio

We are thrilled to have you on board Rachel Jones!

🚀 Exciting news from VedaBio! We’re thrilled to welcome Rachel Jones as our new Chief Commercial Officer. With over 25 years of experience in molecular diagnostics and a track record of successfully launching and scaling transformative technologies, Rachel is the perfect leader to drive the commercialization of our CRISPR-based molecular detection platform. Rachel’s expertise in infectious disease diagnostics and her leadership at companies like Karius and BioFire Diagnostics (now bioMérieux) make her an invaluable addition to our team as we work to redefine the future of molecular detection. Welcome, Rachel! We can’t wait to see the impact you’ll make. #VedaBio #Leadership #MolecularDetection #CRISPR #Diagnostics #Innovation https://lnkd.in/gNxqXdYX

Congratulations to Patrick Hsu, the team at the Arc Institute, and collaborators on Evo 2. This powerful tool will enable scientists across multiple disciplines to gain a deeper understanding of biological complexities. 

Pliancy's latest case study with VedaBio is live now! We recently sat down with Erin R. to discuss building relationships, the impact of in-person support, and how Pliancy helps make IT at VedaBio more manageable. Read the full interview: https://lnkd.in/eAQMXq2w Of course, we must tip our hats to the Pliancy team supporting VedaBio. Thank you Jimmy Josan, Dave Gargula, and Jonathan Schwartz for making the magic happen. ✨

🎄✨ Holiday Fun at VedaBio! ✨🎄 What a fantastic way to kick off the holiday season! Our team had a blast at this year’s holiday party, where we combined culinary creativity with festive flair. 🎅🍽️ We kicked things off with a fun cooking class—whipping up delicious dishes and sharing plenty of laughs. 👩🍳🍴 And what’s a holiday celebration without some festive fashion? Our ugly sweater contest had everyone bringing their A-game. From glittering reindeer to pom-pom covered snowmen, the creativity was truly on display! 🎉🧑🎄 Thank you to all who participated in making this event so memorable. It’s these moments that remind us how lucky we are to work with such an amazing team. 💙 Wishing you all a joyful holiday season filled with love, laughter, and warmth. 🌟 Happy Holidays from all of us at VedaBio! 🎁🎉 #HolidayFun #TeamBuilding #UglySweaterParty #CookingClass #HappyHolidays #SeasonOfGiving #TeamSpirit

On behalf of all of us at VedaBio, big congrats to Patrick Hsu and the entire team at Arc Institute for mind-blowing science! https://lnkd.in/gFz6nYNP https://lnkd.in/gXNd6pT9

🌟 Exciting Announcement at VedaBio! 🌟 We are thrilled to announce that Randy Rasmussen, Ph.D., former CEO of BioFire Diagnostics, has joined VedaBio’s Board of Directors! 🎉 Dr. Rasmussen, a visionary in molecular diagnostics, brings over 30 years of expertise to VedaBio as we move into a critical phase of product development. With his proven track record of scaling innovation, particularly in the realm of syndromic testing for infectious diseases, Randy’s insight will be invaluable in guiding our mission forward. “We are honored to welcome Randy to our Board,” said Frédéric Sweeney, Ph.D., President and CEO of VedaBio. “His leadership in the field and ability to transform technology into commercial success makes him an ideal partner for VedaBio’s next chapter.” Dr. Rasmussen's extensive career includes co-founding Idaho Technology (now BioFire Diagnostics) and leading it to become a global leader in molecular diagnostics with over 3,000 employees and $1B+ in revenue. We are excited to work alongside Dr. Rasmussen and leverage his strategic guidance to bring our breakthrough CRISPR Cascade™ molecular detection platform to market! 📌 Learn more about this exciting development and VedaBio’s technology at https://lnkd.in/gP_SVCs6 #Leadership #Innovation #MolecularDiagnostics #CRISPR #VedaBio #Biotech

🚀 Exciting News from VedaBio! 🚀 We're thrilled to welcome Dr. G. Brett Robb to the VedaBio team as our new Senior Scientific Director and Head of CRISPR Science. With over 16 years of experience and a stellar track record in CRISPR-Cas systems and RNA biology, Brett's expertise will be instrumental in driving the expansion and industrialization of our innovative CRISPR-based molecular detection platform. "His extraordinary leadership, deep knowledge, and strategic vision in CRISPR technology will help propel VedaBio's platform to the next level," says our President and CEO, Dr. Frédéric Sweeney. “Brett's work in CRISPR research and RNA product development has set new industry standards, and we can't wait to see the groundbreaking advancements he'll bring to our team.” Join us in welcoming Brett to VedaBio as we continue to push the boundaries of molecular biology and revolutionize diagnostic testing! #VedaBio #CRISPR #MolecularBiology #Biotechnology #Innovation #Leadership #TeamGrowth https://lnkd.in/gkjig7hj

Last week, VedaBio celebrated our incredible team's hard work with an epic summer party! 🎉 We enjoyed a BBQ hosted by our executives, showed off our competitive spirit with a water balloon toss, took turns in the dunk tank, and had a blast with our exciting raffle. It was a fantastic day filled with laughter, camaraderie, and well-deserved fun. Thank you to everyone who makes VedaBio such a special place to work—here’s to many more moments of joy and celebration! #VedaBio #TeamCelebration #SummerParty 🌞

Welcoming G. Brett Robb, PhD to VedaBio as Advisor – Platform Industrialization. Brett, we’re lucky to have you part of the team and look forward to working with you as we scale our platform!